Better Buy: Amgen vs. Gilead Sciences

Here's a biotech quiz for you. Name a big biotech that's been tremendously successful for a long time, pays an attractive dividend, and is in a transition period. You could have answered correctly with either Amgen (NASDAQ: AMGN) or Gilead Sciences (NASDAQ: GILD).

Gilead has been the bigger winner so far in 2020. Over the last three years, five years, and 10 years, though, Amgen outperformed Gilead. Which of these big biotech stocks is the better pick for investors now?

Image source: Getty Images.

Continue reading

Source Fool.com